Cargando…
Sensitivity of Neuroimaging Indicators in Monitoring the Effects of Interferon Gamma Treatment in Friedreich’s Ataxia
The identification of efficient markers of disease progression and response to possibly effective treatments is a key priority for slowly progressive, rare and neurodegenerative diseases, such as Friedreich’s ataxia. Various imaging modalities have documented specific abnormalities in Friedreich’s a...
Autores principales: | Vavla, Marinela, Arrigoni, Filippo, Toschi, Nicola, Peruzzo, Denis, D’Angelo, Maria Grazia, Gandossini, Sandra, Russo, Annamaria, Diella, Eleonora, Tirelli, Stefania, Salati, Roberto, Rufini, Alessandra, Condo, Ivano, Testi, Roberto, Martinuzzi, Andrea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7583645/ https://www.ncbi.nlm.nih.gov/pubmed/33162876 http://dx.doi.org/10.3389/fnins.2020.00872 |
Ejemplares similares
-
Drug Repositioning in Friedreich Ataxia
por: Rufini, Alessandra, et al.
Publicado: (2022) -
Functional and Structural Brain Damage in Friedreich's Ataxia
por: Vavla, Marinela, et al.
Publicado: (2018) -
Functional MRI Studies in Friedreich's Ataxia: A Systematic Review
por: Vavla, Marinela, et al.
Publicado: (2022) -
Interferon Gamma Enhances Cytoprotective Pathways via Nrf2 and MnSOD Induction in Friedreich’s Ataxia Cells
por: Luffarelli, Riccardo, et al.
Publicado: (2023) -
E3 Ligase RNF126 Directly Ubiquitinates Frataxin, Promoting Its Degradation: Identification of a Potential Therapeutic Target for Friedreich Ataxia
por: Benini, Monica, et al.
Publicado: (2017)